Blog
-
Celebrating 5 years at Albion Languages
Our Senior Project Manager and Training Coordinator, Piroska Ténai is celebrating 5 years at the company. For this occasion we asked her about her favourite memories from the past 5 years, and what she is looking forward to this year.
Read more » -
How to keep patent translation costs under control
Patents are only valid in the country they’re filed in, which means that if you’re planning to go global, you’ll need to have your patent filed in every country you’re interested in. Moreover, most patent offices require applications to be submitted in the country’s native language, which is where patent translation comes in. Read more »
-
Agile localization – what is it and how can it be achieved?
When we hear the word agile, 2 things come to mind. First off, maybe someone sporty, and secondly, you often think of IT and software solutions. With enterprise IT teams already used to Scrum and other such models, their expectations have been changed. And this has meant other departments, like localisation, have had to modernise the way they work, too.
-
A Look At The World Of Sports Translations
If there’s one thing that has the power to unite the world, it’s got to be sport. Ice hockey in Canada, gymnastics in China – no matter where you’re from, there’s going to be a sport you, or your country, loves. But with so many international sporting events taking place around the world, how does the sporting industry deal with the complex language barriers?
-
Getting medical notes translated? Here’s what you need to know.
From the large numbers of private individuals with their own medical notes received abroad to CROs with tens of thousands of hospital reports for clinical trial subjects around the world, it’s no wonder the demand for the translation of medical notes is intense.
-
The dreaded B word – will Brexit have an impact on EU clinical trials?
With only weeks until the cutoff date for Brexit and a no-deal scenario looking more likely by the day, many involved in healthcare are concerned about the future of EU clinical trials and the impact Brexit is going to have on the pharmaceutical industry as a whole. Fortunately, though, the pharmaceutical industry has been keeping a close eye on negotiations to try and get an insight into the potential regulatory framework of the UK post-Brexit.
